BOM/539551 (BOM/539551)

Bombay Stock Exchange: BOM/539551 · INR

₹1,723

+6.55 (+0.4%)· Recorded snapshot

Market cap	350B
Revenue (ttm)	90.7B
Net income (ttm)	8.2B
EPS (ttm)	₹40.2
P/E (trailing)	42.9x
P/E (forward)	29.2x
Dividend	₹4.50 (0.26%)
Volume	8,854

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 90.7B
Net income (ttm): 8.2B
EPS (ttm): ₹40.2
P/E (trailing): 42.9x
P/E (forward): 29.2x
Market cap: 350B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E29.2

P25 n/aP50 n/aP75 n/a

Trailing P/E42.9

P25 n/aP50 n/aP75 n/a

ROE19.8

P25 n/aP50 n/aP75 n/a

ROIC12.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BOM/539551 indicators

Market & fundamental data

Available fields

233

Groups with data

Currency

INR

Showing 233 of 233 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	INR
Country	India
Country code	IN
Earnings date	2026-10-30
Employees	11,234
Employees change	-177
Employees growth	-1.55%
Enterprise value	INR 383.4B
Exchange	Bombay Stock Exchange
Financial currency	INR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	March
Founded	2000
Industry	Medical Care Facilities
Is primary listing	No
ISIN number	INE410P01011
Last earnings date	2026-07-31
Last refreshed	2026-10-28
Market cap	INR 350B
Next earnings date	2026-10-30
Price	INR 1,723.10
Price currency	INR
Sector	Healthcare
SIC code	8062
Stock price date	2026-10-28
Symbol	bom/539551
Website	https://www.narayanahealth.org

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	40.47x
Average P/E ratio (10Y)	59.49x
Average P/E ratio (3Y)	39.23x
Average P/E ratio (5Y)	37.1x
Earnings yield	2.33%
EV/Earnings	46.97x
EV/EBIT	31.36x
EV/EBITDA	22.66x
EV/FCF	51.39x
EV/Sales	4.23x
FCF / EV yield	1.95%
FCF yield	2.13%
Forward P/E	29.2x
Graham number	447.82809
Graham upside	-73.91%
Industry forward P/E	42x
Industry P/E	64.89x
Lynch fair value	INR 1,000.77
Lynch upside	-41.7%
P/B ratio	7.71x
P/E ratio	42.88x
P/FCF ratio	46.91x
P/OCF ratio	21.59x
P/S ratio	3.86x
Price / tangible book value	16.76x
Price/EBITDA ratio	21.6x
Sector forward P/E	36.5x
Sector P/E	46.09x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	13.55%
EBITDA margin	17.85%
Effective tax rate	17.7%
FCF margin	9.45%
Gross margin	39.76%
Operating margin	13.55%
Pretax margin	11%
Profit margin	9%
Profit per employee	INR 726,479
Profitable quarters	23
Profitable years	5
Revenue per employee	INR 8.1M
ROA	7.4%
ROA (5Y)	10.43%
ROCE	10.98%
ROE	19.85%
ROE (5Y)	27.03%
ROIC	12.85%
ROIC (5Y)	22.71%
Tax / revenue	1.95%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	3.95%
EPS growth (Q)	5.37%
EPS growth (QoQ)	-7.44%
EPS growth 10Y	36.95%
EPS growth 3Y	6.29%
EPS growth 5Y	35.06%
EPS growth quarters	2
EPS growth years	5
FCF growth 3Y	9.87%
FCF growth 5Y	26.08%
Gross profit growth	47.1%
Gross profit growth (Q)	68.87%
Gross profit growth 3Y	26.23%
Gross profit growth 5Y	31.26%
Net income growth	3.91%
Net income growth (Q)	5.35%
Net income growth (QoQ)	-7.46%
Net income growth 3Y	6.29%
Net income growth 5Y	35.06%
Net income growth quarters	2
Net income growth years	5
OCF growth	64.46%
OCF growth 10Y	25%
OCF growth 3Y	14.34%
OCF growth 5Y	39.74%
Operating income growth	21.77%
Operating income growth (Q)	24.13%
Operating income growth 3Y	13.79%
Operating income growth 5Y	38.78%
Revenue growth	59.61%
Revenue growth (Q)	78.05%
Revenue growth (QoQ)	3.46%
Revenue growth 10Y	18.32%
Revenue growth 3Y	24.25%
Revenue growth 5Y	24.31%
Revenue growth quarters	22
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	INR -8.8B
Depreciation and amortization	INR 3.9B
EBIT	INR 12.3B
EBITDA	INR 16.2B
EPS	INR 40.19
Financing cash flow	INR 23.4B
Free cash flow	INR 7.5B
Gross profit	INR 36.1B
Income taxes	INR 1.8B
Investing cash flow	INR -37B
Net borrowing	INR 26B
Net cash flow	INR 3.1B
Net income	INR 8.2B
Operating income	INR 12.3B
Revenue	INR 90.7B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	INR 223.40
Debt / EBITDA	3.45
Debt / equity	1.29
Debt / FCF	7.85
Interest coverage	4.31
Net cash (debt)	INR -33.4B
Net cash / market cap	-9.54%
Net debt / EBITDA	2.06
Net debt / equity	0.74
Net debt / FCF	4.47
Piotroski F-Score	5
Shareholders' equity	INR 45.4B
Tangible book value	INR 20.9B
Tangible book value per share	INR 102.84
Total cash	INR 25.2B
Total debt	INR 58.6B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.8
Current ratio	2.15
Inventory turnover	35.84
Quick ratio	1.93
Working capital	INR 21B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.04%
Dividend growth	0%
Dividend growth (3Y)	21.64%
Dividend growth (5Y)	35.1%
Dividend growth years	3
Dividend payment date	2026-09-13
Dividend payment years	5
Dividend payout frequency	Annual
Dividend per share	INR 4.50
Dividend yield	0.26%
Ex-dividend date	2026-07-17
Last dividend	INR 4.50
Payout ratio	11.2%
Shareholder yield	0.3%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	383.2%
10Y return CAGR	17.29%
10Y total return	392.62%
150-day SMA	INR 1,851.88
1D price change	0.38%
1M price change	-7.78%
1M total return	-7.78%
1W price change	-0.54%
1W total return	-0.54%
1Y price change	-0.92%
1Y return CAGR	-0.7%
1Y total return	-0.7%
20-day SMA	INR 1,721.98
200-day SMA	INR 1,839.93
3M price change	-12.52%
3M total return	-12.52%
3Y price change	73.88%
3Y return CAGR	20.56%
3Y total return	75.24%
50-day SMA	INR 1,814.75
50-day SMA vs 200-day SMA	50under200
52-week high	INR 2,094.30
52-week high date	2025-11-17
52-week low	INR 1,564.25
52-week low date	2026-03-30
5Y price change	224.67%
5Y return CAGR	26.86%
5Y total return	228.47%
6M price change	-3.02%
6M total return	-2.8%
All-time high	INR 2,371.60
All-time high date	2025-06-27
All-time low	INR 181.35
All-time low date	2019-05-17
Average true range (ATR)	INR 49.10
Average volume	28.7K
Change from 52-week high	-17.72%
Change from 52-week low	10.16%
Change from all-time high	-27.62%
Change from all-time low	846.54%
Change from open	0.59%
Day's gap	-0.21%
Dollar volume	INR 15.3M
High price	INR 1,733.20
Low price	INR 1,692.05
Monthly RSI	51.51
Open price	INR 1,713.00
Position in 52-week range	75.46%
Previous close	INR 1,716.55
Price vs 150-day SMA	-7.31%
Price vs 20-day SMA	-0.32%
Price vs 200-day SMA	-6.71%
Price vs 50-day SMA	-5.41%
Relative volume	0.31
RSI	44.8
Sharpe ratio	-0.04
Sharpe ratio (3Y)	0.56
Sharpe ratio (5Y)	0.82
Sortino ratio	0.14
Sortino ratio (3Y)	1.13
Sortino ratio (5Y)	1.58
Volume	8.9K
Weekly RSI	42.76
YTD price change	-9.22%
YTD total return	-9.02%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	66M
Shares change (QoQ)	-0.02%
Shares change (YoY)	-0.04%
Shares held by insiders	65.7%
Shares held by institutions	12.98%

Deeper analysis on BOM/539551

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BOM/539551 report

Is a complete BOM/539551 research report available?

No complete published report is available for bom/539551 (BOM/539551) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BOM/539551 (BOM/539551)

Price

Financial snapshot

Fair-value bridge

Latest news · BOM/539551

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BOM/539551 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BOM/539551

Frequently asked questions